ORGANOGENESIS HOLDINGS INC. Tax Withholding Paid on Stock Awards
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Tax Withholding Paid on Stock Awards of $3.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $0.00.
- ORGANOGENESIS HOLDINGS INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $3.05M, a 69.88% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $87.00K, a 4250.00% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $2.00K.
- ORGANOGENESIS HOLDINGS INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $1.89M, a 60.43% increase from fiscal 2024.
- ORGANOGENESIS HOLDINGS INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $1.18M, a 253.92% increase from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $332.00K, a 48.77% decline from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $648.00K, a 12.08% decline from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.05M 10-Q · filed 2026-08-06 | $3.14M derived: sum of 3 quarters · filed 2026-08-06 | $3.14M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $3.05M 10-Q · filed 2026-05-07 | $3.14M derived: sum of 2 quarters · filed 2026-05-07 | $3.14M derived: sum of 3 quarters · filed 2026-05-07 | $3.14M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $89.00K derived: sum of 2 quarters · filed 2026-02-26 | $89.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.89M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.80M 10-Q · filed 2025-11-06 | $1.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.80M 10-Q · filed 2026-08-06 | $1.80M derived: sum of 3 quarters · filed 2026-08-06 | $1.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.80M 10-Q · filed 2026-05-07 | $1.80M derived: sum of 2 quarters · filed 2026-05-07 | $1.80M derived: sum of 3 quarters · filed 2026-05-07 | $1.85M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.00K derived: sum of 2 quarters · filed 2026-02-26 | $55.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.18M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $53.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.17M 10-Q · filed 2025-11-06 | $1.17M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.17M 10-Q · filed 2025-08-07 | $1.17M derived: sum of 3 quarters · filed 2026-02-26 | $1.17M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.12M 10-Q · filed 2025-05-08 | $1.12M derived: sum of 2 quarters · filed 2026-02-26 | $1.12M derived: sum of 3 quarters · filed 2026-02-26 | $1.15M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $34.00K derived: sum of 3 quarters · filed 2026-02-26 | $332.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $35.00K derived: sum of 2 quarters · filed 2024-11-12 | $333.00K 10-Q · filed 2024-11-12 | $333.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $332.00K 10-Q · filed 2024-08-08 | $332.00K derived: sum of 3 quarters · filed 2025-02-27 | $334.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $298.00K 10-Q · filed 2024-05-09 | $298.00K derived: sum of 2 quarters · filed 2025-02-27 | $300.00K derived: sum of 3 quarters · filed 2025-02-27 | $458.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.00K derived: sum of 2 quarters · filed 2025-02-27 | $160.00K derived: sum of 3 quarters · filed 2025-02-27 | $648.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $160.00K derived: sum of 2 quarters · filed 2023-11-09 | $648.00K 10-Q · filed 2023-11-09 | $648.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $646.00K 10-Q · filed 2023-08-09 | $646.00K derived: sum of 3 quarters · filed 2024-02-29 | $646.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $488.00K 10-Q · filed 2023-05-10 | $488.00K derived: sum of 2 quarters · filed 2024-02-29 | $488.00K derived: sum of 3 quarters · filed 2024-02-29 | $808.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $320.00K derived: sum of 3 quarters · filed 2024-02-29 | $737.00K 10-K · filed 2024-02-29 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $320.00K derived: sum of 2 quarters · filed 2022-11-09 | $737.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $320.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $737.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $417.00K 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |